Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global Life Science analytics market is expected to register a CAGR of nearly 12.5 % during the forecast period, 2018-2023. The application of analytics has emerged as a useful tool for numerous pharmaceutical, medical device and biotechnological enterprises, as these choices help to overcome challenges in data integration and enhance operational efficiency. The key applications of analytics in pharmaceutical and life sciences include regulatory compliance reporting, marketing and product or service enablement.
Increasing Adoption of Analytics Solutions in Pharmaceuticals and Clinical Trials
There is a rise in use of analytics in clinical trials as the clinical trials conduction has become a complex process where it involves many activities and generates high volumes of data from different systems. With changing regulatory protocol requirements for clinical trial conduction and challenge in data collection, analyzing and report preparation for quick submission to health authority, hence the use of analytics in clinical trials is rising.
Analytics will help in optimizing the drug discovery and improve the efficiency of clinical trials. With huge data generated from Research & Development process and clinical research, the pharma companies can identify potential drug candidates with high probability of successfully developing in to drugs. Most contract research organizations (CROs) with established systems for Data capture, advanced analytics are now incorporated across all systems such as drug discovery, clinical development and CRO’s which is providing real time analysis and creating alerts to each divisions concerning safety or efficacy. Application of analytics in evaluating a potential drug candidate for clinical development may reduce the time and R&D expenditure. Eli Lilly’s has developed Phenotypic Drug Discovery Platform, where researchers can screen their compounds without giving intellectual property. The importance of Real-time analysis has become more important to pharmaceutical companies as payers impose value-based pricing, health authorities offering incentives for health outcomes. Some companies are in creating networks to collect, analyze, share and respond to queries on health outcomes.
Other factors that drive this market include advancements in technology, and growing pressure to reduce healthcare spending.
High Implementation Costs
Life science companies that include Pharma, contract research organization (CRO) and others face increasing pressure to allocate budget in establishing infrastructure for analytics division. Many companies in the past never had a clear understanding about the role of analytics in Pharma or clinical trials. Those companies that recognized the importance of analytics have established their own in house analytics department or outsourced to third party their requirement.
Costs increase sometimes if a company they have bought a subscription based analytical tool for their business and after a period of time realize that the selected analytical tool doesn't meet their business needs. All the costs associated with installation and implementation processes are lost investment for the company. Major companies like Pfizer with deep pockets to invest already have their own Real World Data and Analytics centers and applying those analytics-generated insights to deliver personalized care services. Mid-size and small companies pose high cost for partnering with established analytics companies to explore their strategy for business development opportunities. Hence, high implementation costs are restraining the growth of life science analytics market.
Other factor impeding this market include lack of skilled personnel.
US dominates the North American Region For Life Science Analytics Market
The US accounts for the largest share in the North America region for the market studied. This can be primarily attributed to presence of more number of pharmaceutical companies and even more number of clinical trials are occurring in this region, which are expected to augment the growth of the market studied over the forecast period.
Key Developments in the Life Science Analytics Market
• May 2018: Sanofi Chooses Accenture Interactive to Create UWell’s Healthcare Platform to Better Serve Consumers.
Major Players: ORACLE CORPORATION, QUINTILES, INC., SAS INSTITUTE INC., IBM CORPORATION, MAXISIT, SCIO HEALTH ANALYTICS, TAKE SOLUTIONS, WIPRO LIMITED, ACCENTURE, COGNIZANT, among others.
Reasons to Purchase Life Science Analytics Market Report
• Current and future of Life Science analytics market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in Excel)
Customization of Life Science Analytics Market Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
Increasing Adoption of Analytics Solutions in Pharmaceuticals and Clinical Trials
There is a rise in use of analytics in clinical trials as the clinical trials conduction has become a complex process where it involves many activities and generates high volumes of data from different systems. With changing regulatory protocol requirements for clinical trial conduction and challenge in data collection, analyzing and report preparation for quick submission to health authority, hence the use of analytics in clinical trials is rising.
Analytics will help in optimizing the drug discovery and improve the efficiency of clinical trials. With huge data generated from Research & Development process and clinical research, the pharma companies can identify potential drug candidates with high probability of successfully developing in to drugs. Most contract research organizations (CROs) with established systems for Data capture, advanced analytics are now incorporated across all systems such as drug discovery, clinical development and CRO’s which is providing real time analysis and creating alerts to each divisions concerning safety or efficacy. Application of analytics in evaluating a potential drug candidate for clinical development may reduce the time and R&D expenditure. Eli Lilly’s has developed Phenotypic Drug Discovery Platform, where researchers can screen their compounds without giving intellectual property. The importance of Real-time analysis has become more important to pharmaceutical companies as payers impose value-based pricing, health authorities offering incentives for health outcomes. Some companies are in creating networks to collect, analyze, share and respond to queries on health outcomes.
Other factors that drive this market include advancements in technology, and growing pressure to reduce healthcare spending.
High Implementation Costs
Life science companies that include Pharma, contract research organization (CRO) and others face increasing pressure to allocate budget in establishing infrastructure for analytics division. Many companies in the past never had a clear understanding about the role of analytics in Pharma or clinical trials. Those companies that recognized the importance of analytics have established their own in house analytics department or outsourced to third party their requirement.
Costs increase sometimes if a company they have bought a subscription based analytical tool for their business and after a period of time realize that the selected analytical tool doesn't meet their business needs. All the costs associated with installation and implementation processes are lost investment for the company. Major companies like Pfizer with deep pockets to invest already have their own Real World Data and Analytics centers and applying those analytics-generated insights to deliver personalized care services. Mid-size and small companies pose high cost for partnering with established analytics companies to explore their strategy for business development opportunities. Hence, high implementation costs are restraining the growth of life science analytics market.
Other factor impeding this market include lack of skilled personnel.
US dominates the North American Region For Life Science Analytics Market
The US accounts for the largest share in the North America region for the market studied. This can be primarily attributed to presence of more number of pharmaceutical companies and even more number of clinical trials are occurring in this region, which are expected to augment the growth of the market studied over the forecast period.
Key Developments in the Life Science Analytics Market
• May 2018: Sanofi Chooses Accenture Interactive to Create UWell’s Healthcare Platform to Better Serve Consumers.
Major Players: ORACLE CORPORATION, QUINTILES, INC., SAS INSTITUTE INC., IBM CORPORATION, MAXISIT, SCIO HEALTH ANALYTICS, TAKE SOLUTIONS, WIPRO LIMITED, ACCENTURE, COGNIZANT, among others.
Reasons to Purchase Life Science Analytics Market Report
• Current and future of Life Science analytics market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in Excel)
Customization of Life Science Analytics Market Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
